David Azzopardi

614 total citations
15 papers, 467 citations indexed

About

David Azzopardi is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Azzopardi has authored 15 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Azzopardi's work include Smoking Behavior and Cessation (10 papers), Air Quality and Health Impacts (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). David Azzopardi is often cited by papers focused on Smoking Behavior and Cessation (10 papers), Air Quality and Health Impacts (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). David Azzopardi collaborates with scholars based in United Kingdom and United States. David Azzopardi's co-authors include James J. Murphy, Marianna Gaça, Chuan Liu, John McAughey, Oscar M. Camacho, Jason Adamson, Linsey E. Haswell, Tomasz Jaunky, Michael McEwan and George Hardie and has published in prestigious journals such as Scientific Reports, Food and Chemical Toxicology and Toxicology in Vitro.

In The Last Decade

David Azzopardi

14 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Azzopardi United Kingdom 10 268 148 123 105 103 15 467
Tanvir Walele United States 14 408 1.5× 200 1.4× 140 1.1× 92 0.9× 88 0.9× 18 572
Tomasz Jaunky United Kingdom 10 228 0.9× 193 1.3× 90 0.7× 115 1.1× 48 0.5× 14 412
Serge Maeder Switzerland 8 240 0.9× 258 1.7× 59 0.5× 91 0.9× 44 0.4× 13 472
Stacy Fiebelkorn United Kingdom 6 139 0.5× 142 1.0× 52 0.4× 71 0.7× 29 0.3× 12 317
Jason Adamson United Kingdom 18 268 1.0× 417 2.8× 130 1.1× 299 2.8× 224 2.2× 24 772
P. McDonald United Kingdom 6 82 0.3× 78 0.5× 64 0.5× 44 0.4× 98 1.0× 11 305
Amina A. Ford United States 5 234 0.9× 71 0.5× 117 1.0× 13 0.1× 227 2.2× 6 515
George Hardie United Kingdom 11 241 0.9× 45 0.3× 99 0.8× 23 0.2× 42 0.4× 20 298
Karolien Bloemen Belgium 8 193 0.7× 60 0.4× 44 0.4× 10 0.1× 130 1.3× 8 407
Yiping Xu China 12 65 0.2× 43 0.3× 146 1.2× 46 0.4× 31 0.3× 43 453

Countries citing papers authored by David Azzopardi

Since Specialization
Citations

This map shows the geographic impact of David Azzopardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Azzopardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Azzopardi more than expected).

Fields of papers citing papers by David Azzopardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Azzopardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Azzopardi. The network helps show where David Azzopardi may publish in the future.

Co-authorship network of co-authors of David Azzopardi

This figure shows the co-authorship network connecting the top 25 collaborators of David Azzopardi. A scholar is included among the top collaborators of David Azzopardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Azzopardi. David Azzopardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Azzopardi, David, Elaine Brown, Stacy Fiebelkorn, et al.. (2025). A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers. The Journal of Clinical Pharmacology. 66(1). e70090–e70090.
2.
Haswell, Linsey E., Nathan Gale, Elaine Brown, et al.. (2023). Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers. Internal and Emergency Medicine. 18(5). 1359–1371. 3 indexed citations
3.
4.
Azzopardi, David, Michael McEwan, Oscar M. Camacho, et al.. (2022). A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products. Scientific Reports. 12(1). 6949–6949. 31 indexed citations
5.
6.
7.
McEwan, Michael, David Azzopardi, Nathan Gale, et al.. (2021). A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette. European Journal of Drug Metabolism and Pharmacokinetics. 47(2). 211–221. 40 indexed citations
8.
Azzopardi, David, Chuan Liu, & James J. Murphy. (2021). Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums. Drug and Chemical Toxicology. 45(5). 2246–2254. 85 indexed citations
9.
10.
11.
Breheny, Damien, Jason Adamson, David Azzopardi, et al.. (2017). A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products. Food and Chemical Toxicology. 106(Pt A). 533–546. 28 indexed citations
12.
Azzopardi, David, et al.. (2016). Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicology Mechanisms and Methods. 26(6). 477–491. 87 indexed citations
13.
Azzopardi, David, et al.. (2015). Evaluation of an air–liquid interface cell culture model for studies on the inflammatory and cytotoxic responses to tobacco smoke aerosols. Toxicology in Vitro. 29(7). 1720–1728. 56 indexed citations
14.
Adamson, Jason, et al.. (2012). Real-time assessment of cigarette smoke particle deposition in vitro. Chemistry Central Journal. 6(1). 98–98. 31 indexed citations
15.
Adamson, Jason, David Azzopardi, Graham Errington, et al.. (2011). Assessment of an in vitro whole cigarette smoke exposure system: The Borgwaldt RM20S 8-syringe smoking machine. Chemistry Central Journal. 5(1). 50–50. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanvir Walele Breakdown of academic impact, for papers by Tomasz Jaunky Breakdown of academic impact, for papers by Serge Maeder Breakdown of academic impact, for papers by Stacy Fiebelkorn Breakdown of academic impact, for papers by Jason Adamson Breakdown of academic impact, for papers by P. McDonald Breakdown of academic impact, for papers by Amina A. Ford Breakdown of academic impact, for papers by George Hardie Breakdown of academic impact, for papers by Karolien Bloemen Breakdown of academic impact, for papers by Yiping Xu
Rankless by CCL
2026